Fundamentals
RegeneRx is currently developing drug candidates and does not yet have revenue generating drug products. Consequently, some of the following financial measurements are not applicable. Furthermore, RegeneRx operates an out-sourced business model, meaning that the Company employs only a few key employees directly. Theses employees manage a variety of out-sourced relationships including: drug manufacture, drug formulation, preclinical and clinical trials, and administrative functions such as accounting. This strategy effectively reduces the need for expensive infrastructure, enabling management to concentrate on specific clinical objectives to maximize shareholder value. | In Millions of U.S. Dollars |
|  | | | | | Fiscal Yr. Ending - 12/31/07 |
|
| | | | | | | | | |
|
| Data Provided by Thomson Financial |
|
